Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.

Bilici A, Inanc M, Ulas A, Akman T, Seker M, Babacan NA, Inal A, Bal O, Koral L, Sevinc A, Tufan G, Elkiran ET, Ustaalioglu BB, Yavuzsen T, Alkis N, Ozkan M, Gumus M.

Asian Pac J Cancer Prev. 2014 Jan;14(11):6493-9.

2.

Clinical and pathologic features of patients with non-epithelial ovarian cancer: retrospective analysis of a single institution 15-year experience.

Kempf E, Desamericq G, Vieites B, Diaz-Padilla I, Calvo E, Estevez P, Garcia-Arreza A, Martinez-Maestre MA, Duran I.

Clin Transl Oncol. 2017 Feb;19(2):173-179. doi: 10.1007/s12094-016-1517-x. Epub 2016 May 18.

PMID:
27193130
3.

An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.

Yang ZJ, Liu ZC, Wei RJ, Li L.

Gynecol Obstet Invest. 2016;81(1):1-9. doi: 10.1159/000381771. Epub 2015 May 1.

PMID:
25967958
4.

Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.

Zhang M, Cheung MK, Shin JY, Kapp DS, Husain A, Teng NN, Berek JS, Osann K, Chan JK.

Gynecol Oncol. 2007 Feb;104(2):396-400. Epub 2006 Oct 9.

PMID:
17030354
5.

Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.

Chan JK, Zhang M, Kaleb V, Loizzi V, Benjamin J, Vasilev S, Osann K, Disaia PJ.

Gynecol Oncol. 2005 Jan;96(1):204-9.

PMID:
15589602
6.

Laparoscopic management of early-stage malignant nonepithelial ovarian tumors: surgical and survival outcomes.

Shim SH, Kim DY, Lee SW, Park JY, Kim JH, Kim YM, Kim YT, Nam JH.

Int J Gynecol Cancer. 2013 Feb;23(2):249-55. doi: 10.1097/IGC.0b013e318272e754.

PMID:
23318909
7.

Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patients.

Ray-Coquard I, Weber B, Lotz JP, Tournigand C, Provencal J, Mayeur D, Treilleux I, Paraiso D, Duvillard P, Pujade-Lauraine E; GINECO group.

Gynecol Oncol. 2010 Oct;119(1):53-9. doi: 10.1016/j.ygyno.2010.05.023. Epub 2010 Jun 30.

PMID:
20580063
8.

Prognostic factors of germ cell and sex cord-stromal ovarian tumors in pediatric age: 5 years experience.

Elashry R, Hemida R, Goda H, Abdel-Hady el-S.

J Exp Ther Oncol. 2013;10(3):181-7.

PMID:
24416992
9.

Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.

Mangili G, Sigismondi C, Gadducci A, Cormio G, Scollo P, Tateo S, Ferrandina G, Greggi S, Candiani M, Lorusso D.

Int J Gynecol Cancer. 2011 Nov;21(8):1414-21. doi: 10.1097/IGC.0b013e3182236582.

PMID:
21795985
10.

Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.

Ghaemmaghami F, Hasanzadeh M, Karimi Zarchi M, Fallahi A.

Int J Surg. 2008 Oct;6(5):382-6. doi: 10.1016/j.ijsu.2008.07.002. Epub 2008 Jul 16.

11.

Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.

Tangjitgamol S, Hanprasertpong J, Manusirivithaya S, Wootipoom V, Thavaramara T, Buhachat R.

Acta Obstet Gynecol Scand. 2010;89(2):182-9. doi: 10.3109/00016340903443684.

PMID:
19961281
12.

Management and prognosis of patients with ovarian sex cord tumor with annular tubules: a retrospective study.

Qian Q, You Y, Yang J, Cao D, Zhu Z, Wu M, Chen J, Lang J, Shen K.

BMC Cancer. 2015 Apr 12;15:270. doi: 10.1186/s12885-015-1277-y.

13.

Patterns and progress in ovarian cancer over 14 years.

Chan JK, Cheung MK, Husain A, Teng NN, West D, Whittemore AS, Berek JS, Osann K.

Obstet Gynecol. 2006 Sep;108(3 Pt 1):521-8.

PMID:
16946210
14.

[Multicenter randomized controlled clinical study for the operative treatment of malignant ovarian germ cell tumors].

Liu Q, Ding XL, Yang JX, Cao DY, Shen K, Lang JH, Zhang GN, Xin XY, Xie X, Zhang SL, Wu YM, Zhu GH, Wang J, Chen YL, Kong BH, Zheng JH.

Zhonghua Fu Chan Ke Za Zhi. 2013 Mar;48(3):188-92. Chinese.

PMID:
23849941
15.

[Analysis of prognostic factors of malignant ovarian tumor after fertility-preserving treatment].

Zeng DY, Shen K, Huang HF, Wu M, Pan LY, Yang JX, Lang JH.

Zhonghua Yi Xue Za Zhi. 2005 Sep 21;85(36):2562-5. Chinese.

PMID:
16321304
16.

Patterns of spread and recurrence of sex cord-stromal tumors of the ovary.

Thrall MM, Paley P, Pizer E, Garcia R, Goff BA.

Gynecol Oncol. 2011 Aug;122(2):242-5. doi: 10.1016/j.ygyno.2011.03.020. Epub 2011 Apr 9.

17.

Clinicopathologic analysis of early-stage sporadic ovarian carcinoma.

Leitao MM Jr, Boyd J, Hummer A, Olvera N, Arroyo CD, Venkatraman E, Baergen RN, Dizon DS, Barakat RR, Soslow RA.

Am J Surg Pathol. 2004 Feb;28(2):147-59.

PMID:
15043303
18.

"The impact of debulking surgery in patients with node-positive epithelial ovarian cancer: Analysis of prognostic factors related to overall survival and progression-free survival after an extended long-term follow-up period".

Pereira A, Pérez-Medina T, Magrina JF, Magtibay PM, Rodríguez-Tapia A, Cuesta-Guardiola T, Peregrin I, Mendizabal E, Lizarraga S, Ortiz-Quintana L.

Surg Oncol. 2016 Mar;25(1):49-59. doi: 10.1016/j.suronc.2015.12.005. Epub 2016 Feb 10.

PMID:
26979641
19.

[Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].

Tu H, Huang H, Huang QD, Li Z, Feng YL, Liu JH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Dec;47(12):928-33. Chinese.

PMID:
23324194
20.

Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.

Lee CW, Song MJ, Park ST, Ki EY, Lee SJ, Lee KH, Ryu KS, Park JS, Hur SY.

World J Surg Oncol. 2011 Oct 11;9:123. doi: 10.1186/1477-7819-9-123.

Supplemental Content

Support Center